Clinical trial

Safety and Tolerability Evaluation Study of BVAC-B in Patients With HER2/Neu(Human Epithelial Growth Factor Receptor 2) Positive Gastric Cancer After Failure to Standard Care

NCT03425773

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-02-26

PhasePHASE1

Study timeline

Study start (actual)2018-02-26Date precision: day

Registry last updated2020-02-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Stomach Neoplasmsunresolved

Interventions

BVAC-BBIOLOGICAL

Sponsors & collaborators

Cellid Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03425773 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.